D. E. Shaw & Co., Inc. Novartis Ag Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Novartis Ag stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 48,424 shares of NVS stock, worth $4.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,424

Holding current value

$4.76 Million

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $4.84 Million - $5.51 Million	45,588 Added 1607.48%	48,424 $5.57 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $262,528 - $304,501	2,836 New	2,836 $301,000
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $6.47 Million - $7.12 Million	-70,106 Reduced 56.12%	54,817 $5.53 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $13.5 Million - $14.9 Million	-142,019 Reduced 53.2%	124,923 $12.7 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $24.4 Million - $27.7 Million	264,142 Added 9433.64%	266,942 $26.9 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $1.65 Million - $1.92 Million	-20,643 Reduced 88.06%	2,800 $257,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $1.26 Million - $1.54 Million	16,678 Added 246.53%	23,443 $2.13 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $17.7 Million - $20.6 Million	-236,647 Reduced 97.22%	6,765 $514,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $19 Million - $22.2 Million	-236,477 Reduced 49.28%	243,412 $20.6 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $107 Million - $121 Million	-1,340,015 Reduced 73.63%	479,889 $42.1 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $143 Million - $158 Million	1,793,934 Added 6907.72%	1,819,904 $159 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $1.25 Million - $1.46 Million	15,329 Added 144.06%	25,970 $2.12 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $2.26 Million - $2.5 Million	-26,517 Reduced 71.36%	10,641 $971,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $488,158 - $540,813	5,943 Added 19.04%	37,158 $3.23 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $26.8 Million - $30.2 Million	-331,035 Reduced 91.38%	31,215 $2.73 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $25.1 Million - $35.1 Million	354,885 Added 4818.53%	362,250 $29.9 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $621,237 - $702,400	7,365 New	7,365 $697,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $7 Million - $8.61 Million	-92,782 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $47.5 Million - $54.3 Million	-630,074 Reduced 87.16%	92,782 $8.92 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $38.8 Million - $43.2 Million	526,127 Added 267.44%	722,856 $62 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $57.3 Million - $66.3 Million	-855,956 Reduced 81.31%	196,729 $17 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $66.6 Million - $75.3 Million	1,025,932 Added 3834.83%	1,052,685 $79.5 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $1.88 Million - $2.25 Million	26,753 New	26,753 $2.16 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $8.55 Million - $9.18 Million	-118,216 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $8.76 Million - $9.13 Million	118,216	118,216 $10.1 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account